Insider Cluster (4 insiders) ·Filed Aug 6, 2026

CORT

CORCEPT THERAPEUTICS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 3 insiders, $3.9M total
Actionable Insight • Neutral

Sales are negligible relative to market cap and follow option exercises — consistent with routine liquidity/vesting activity. No bearish read-through. Monitor next earnings for fundamental signals.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
CORT ▲ +0.77% at T+20d
NEUTRAL call ✓ call won +0.77% · α vs SPY +1.16% · entry $110.77 → $111.62
Next anchor: T+60d in 28d
Latest observation: T+38 -38.90% FF3 residual α
Entry anchored
Aug 6, 04:00 PM ET
via 1-min bar
T+1d
+3.12%
call +3.12% · α +3.15%
$114.23
settled 8w ago
T+5d
+3.34%
call +3.34% · α +2.94%
$114.47
settled 7w ago
T+20d
+0.77%
call +0.77% · α +1.16%
$111.62
settled 29d ago
T+60d
—
call — · α —
—
in 28d

Price Chart

Loading chart...

Executive Summary

Three executives at Corcept Therapeutics sold a combined $3.88M in open-market stock over a 7-day window, including the CFO and Chief Development Officer. At a $12B market cap, this represents ~0.03% — a trivial proportion — making it routine portfolio diversification rather than a bearish signal. The sales follow recent option exercises and align with typical vesting-related liquidity patterns.

Key Financial Metrics

Direction
selling
Total Value
$3.9M
Insiders
4

Key Facts

  • Three insiders sold $3.88M total in open-market sales over 7 days.
  • Total sales represent ~0.03% of the $12.0B market cap.
  • CFO Atabak Mokari sold 9,000 shares ($958K) at $106.96.
  • Sean Maduck sold 20,305 shares ($2.33M) at $114.70 after exercising options.
  • William Guyer sold 3,700 shares ($419K) at $113.12 after exercising options.
  • Joseph Lyon sold 1,540 shares ($176K) at $114.16.
  • No open-market purchases were recorded in the cluster.

Financial Impact

0.03% of market cap sold — trivial

insider cash-outdilution from option exercises

Risk Factors

  • Insider selling may intensify ahead of a catalyst (upcoming earnings or trial data).
  • Option exercises could precede further open-market sales from other executives.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CORT-1786057272652
26 reports for CORT
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +63.06%Feb 24, 2026
Filters
Rows
Reports for CORT — sortable, filterable
TypeNow
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $115.63▲ +1.54%▲ +1.28%$116.49 (+2.29%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $116.10▲ +1.95%▲ +1.44%$116.49 (+2.29%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$116.93 $117.00▲ +0.06%▲ +0.16%$116.49 (−0.38%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$121.05 $114.86▼ −5.11%▼ −5.11%$116.49 (−3.77%)
Aug 18, 2026
6w ago
Insider Cluster
BEARISH ★ 4/10
$118.10 $111.85▲ +5.29%▲ +4.30%$116.49 (+1.36%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.49 (+3.84%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.49 (+3.84%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$110.77 $111.62▲ +0.77%▲ +1.16%$116.49 (+5.16%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.95 $112.80▲ +4.49%▲ +3.89%$116.49 (+7.91%)
Jul 23, 2026
10w ago
Court Ruling
BULLISH ★ 4/10
$96.66 $121.05▲ +25.23%▲ +21.92%$116.49 (+20.52%)
Showing 10 of 26

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 6, 2026